BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 21815866)

  • 21. Characteristics of serious complicated gastroduodenal ulcers in Japan.
    Ishikawa S; Inaba T; Mizuno M; Miyake Y; Okada H; Ishikawa H; Hori K; Wato M; Kawai K; Yamamoto K
    Hepatogastroenterology; 2012; 59(113):147-54. PubMed ID: 22251530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More favorable outcomes with peptic ulcer bleeding due to Helicobacter pylori.
    Chason RD; Reisch JS; Rockey DC
    Am J Med; 2013 Sep; 126(9):811-818.e1. PubMed ID: 23830535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors for peptic ulcer bleeding].
    Søberg T; Hofstad B; Sandvik L; Johansen M; Lygren I
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1135-9. PubMed ID: 20531499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention.
    Hiew C; Duggan A; de Malmanche T; Hatton R; Baker F; Attia J; Collins N
    Intern Med J; 2012 Mar; 42(3):289-93. PubMed ID: 20492005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
    Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J
    N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.
    Mahachai V; Thomson AB; Vilaichone RK
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S295-9. PubMed ID: 16083206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
    Zullo A; Hassan C; Campo SM; Morini S
    Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Helicobacter pylori infection in peptic ulcer haemorrhage.
    Morgando A; Giordanino C; Baronio M; Pellicano R; Rizzetto M
    Minerva Med; 2006 Feb; 97(1):47-50. PubMed ID: 16565698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
    Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
    Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer.
    Colin R; Czernichow P; Baty V; Touzé I; Brazier F; Bretagne JF; Berkelmans I; Barthélémy P; Hemet J
    Gastroenterol Clin Biol; 2000 Jan; 24(1):31-5. PubMed ID: 10679585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
    Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
    Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress?
    Aoyama N; Shinoda Y; Matsushima Y; Shirasaka D; Kinoshita Y; Kasuga M; Chiba T
    J Gastroenterol; 2000; 35 Suppl 12():33-7. PubMed ID: 10779215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 38. Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers.
    Lin HJ; Lo WC; Perng CL; Li AF; Tseng GY; Sun IC; Ou YH
    Helicobacter; 2004 Dec; 9(6):663-8. PubMed ID: 15610081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in peptic ulcer between the East and the West.
    Leong RW
    Gastroenterol Clin North Am; 2009 Jun; 38(2):363-79. PubMed ID: 19446264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.